HPAI endorses the AllTrials campaign to have all clinical trials registered and all subsequent findings fully disclosed. In the interests of patient safety and to facilitate good decision making, hospital pharmacists need access to all relevant information about medicines arising from clinical trials. To deny access to information is to impair provision of optimum patient care.
